TVTX Insider Trading

Insider Ownership Percentage: 4.06%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,164,946.05

Travere Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Travere Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Travere Therapeutics Share Price & Price History

Current Price: $19.58
Price Change: Price Increase of +0.01 (0.05%)
As of 12/3/2024 01:26 PM ET

This chart shows the closing price history over time for TVTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Travere Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/25/2024Sandra CalvinCAOSell12,090$18.30$221,247.0054,927View SEC Filing Icon  
10/4/2024Gary A LyonsDirectorSell40,000$14.73$589,200.0051,000View SEC Filing Icon  
9/30/2024Jeffrey A MecklerDirectorSell40,000$14.06$562,400.0081,000View SEC Filing Icon  
9/9/2024Christopher R ClineCFOSell2,490$11.52$28,684.8074,595View SEC Filing Icon  
9/9/2024Eric M. DubeCEOSell21,125$11.52$243,360.00361,975View SEC Filing Icon  
9/9/2024Jula InrigInsiderSell2,191$11.52$25,240.3262,633View SEC Filing Icon  
9/9/2024William E. RoteSVPSell4,387$11.52$50,538.2484,455View SEC Filing Icon  
9/4/2024Christopher R ClineCFOSell514$9.51$4,888.1470,335View SEC Filing Icon  
4/11/2024Christopher R ClineCFOSell54$6.74$363.9670,849View SEC Filing Icon  
2/1/2024Christopher R ClineCFOSell3,818$8.53$32,567.5470,903View SEC Filing Icon  
2/1/2024Eric M. DubeCEOSell19,122$8.70$166,361.40350,600View SEC Filing Icon  
2/1/2024Peter HeermaInsiderSell4,195$8.53$35,783.3599,503View SEC Filing Icon  
2/1/2024Sandra CalvinCAOSell2,820$8.53$24,054.6052,017View SEC Filing Icon  
2/1/2024William E. RoteSVPSell4,764$8.71$41,494.4480,720View SEC Filing Icon  
1/23/2024Christopher R ClineCFOSell853$9.07$7,736.7149,721View SEC Filing Icon  
1/23/2024Elizabeth E. ReedSVPSell2,062$8.96$18,475.5256,034View SEC Filing Icon  
1/23/2024Eric M. DubeCEOSell7,873$8.96$70,542.08234,722View SEC Filing Icon  
1/23/2024Peter HeermaInsiderSell1,559$9.07$14,140.1378,698View SEC Filing Icon  
1/23/2024Sandra CalvinCAOSell910$9.07$8,253.7041,337View SEC Filing Icon  
1/3/2024Jula InrigInsiderSell2,069$9.48$19,614.1235,688View SEC Filing Icon  
10/3/2023Peter HeermaInsiderSell3,091$8.25$25,500.7580,257View SEC Filing Icon  
9/5/2023Christopher R ClineCFOSell457$14.71$6,722.4750,574View SEC Filing Icon  
9/5/2023Eric M. DubeCEOSell4,455$14.71$65,533.05242,595View SEC Filing Icon  
9/5/2023William E. RoteSVPSell1,815$14.71$26,698.6561,173View SEC Filing Icon  
5/10/2023Christopher R ClineCFOSell455$16.59$7,548.4551,031View SEC Filing Icon  
5/10/2023Elizabeth E. ReedSVPSell825$16.59$13,686.7556,611View SEC Filing Icon  
5/10/2023Sandra CalvinCAOSell436$16.59$7,233.2442,369View SEC Filing Icon  
4/11/2023Christopher R ClineCFOSell47$21.49$1,010.0351,486View SEC Filing Icon  
2/1/2023Christopher R ClineCFOSell1,588$21.75$34,539.0051,533View SEC Filing Icon  
2/1/2023Elizabeth E. ReedSVPSell2,590$22.25$57,627.5057,436View SEC Filing Icon  
2/1/2023Eric M. DubeCEOSell8,196$22.25$182,361.00237,150View SEC Filing Icon  
2/1/2023Peter HeermaInsiderSell1,779$21.75$38,693.2582,069View SEC Filing Icon  
2/1/2023Sandra CalvinCAOSell1,671$21.75$36,344.2543,165View SEC Filing Icon  
1/24/2023Christopher R ClineCFOSell852$21.90$18,658.8032,871View SEC Filing Icon  
1/24/2023Eric M. DubeCEOSell6,442$21.50$138,503.00147,846View SEC Filing Icon  
1/24/2023Peter HeermaInsiderSell1,550$21.90$33,945.0063,598View SEC Filing Icon  
1/24/2023Sandra CalvinCAOSell905$21.90$19,819.5035,028View SEC Filing Icon  
1/24/2023William E. RoteSVPSell2,062$21.50$44,333.0042,376View SEC Filing Icon  
1/5/2023Eric M. DubeCEOSell5,625$20.75$116,718.75154,288View SEC Filing Icon  
1/4/2023Jula InrigInsiderSell2,051$20.75$42,558.2517,949View SEC Filing Icon  
10/4/2022Peter HeermaInsiderSell3,042$25.68$78,118.5665,148View SEC Filing Icon  
9/13/2022Sandra CalvinCAOSell349$28.00$9,772.0035,933View SEC Filing Icon  
5/11/2022Steve AselageDirectorSell2,575$21.92$56,444.00146,919View SEC Filing Icon  
5/11/2022William E. RoteSVPSell1,563$21.71$33,932.7343,672View SEC Filing Icon  
5/10/2022Laura ClagueCFOSell825$21.51$17,745.7537,030View SEC Filing Icon  
5/10/2022Sandra CalvinCAOSell436$21.51$9,378.3636,178View SEC Filing Icon  
1/31/2022Elizabeth E. ReedSVPSell1,350$27.40$36,990.00View SEC Filing Icon  
1/31/2022Eric M. DubeCEOSell4,813$27.40$131,876.20View SEC Filing Icon  
1/31/2022Laura ClagueCFOSell1,238$27.40$33,921.20View SEC Filing Icon  
1/31/2022Peter HeermaInsiderSell1,125$27.40$30,825.00View SEC Filing Icon  
1/31/2022Sandra CalvinCAOSell798$26.51$21,154.98View SEC Filing Icon  
1/24/2022Eric M. DubeCEOSell7,873$24.98$196,667.54View SEC Filing Icon  
1/24/2022Laura ClagueCFOSell2,063$24.98$51,533.74View SEC Filing Icon  
1/24/2022Sandra CalvinCAOSell934$24.58$22,957.72View SEC Filing Icon  
1/24/2022William E. RoteSVPSell1,875$24.98$46,837.50View SEC Filing Icon  
1/11/2022Elizabeth E. ReedSVPSell5,000$27.40$137,000.00View SEC Filing Icon  
1/11/2022Laura ClagueCFOSell7,500$27.40$205,500.00View SEC Filing Icon  
1/4/2022Eric M. DubeCEOSell4,832$30.43$147,037.76View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Travere Therapeutics (NASDAQ:TVTX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TVTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Travere Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2024Virtu Financial LLC21,500$0.30M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,731,045$24.22M0.0%+3.9%2.218%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC168,768$2.36M0.0%-9.4%0.216%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd28,217$0.40M0.0%-70.4%0.036%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd14,205$0.20M0.0%-73.8%0.018%Search for SEC Filing on Google Icon
11/15/2024Two Sigma Advisers LP720,400$10.08M0.0%+30.2%0.923%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,736,696$38.29M0.0%-22.0%3.506%Search for SEC Filing on Google Icon
11/15/2024Quarry LP7,500$0.11M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC1,086,067$15.19M1.9%+12.0%1.392%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.1,590,377$22.25M0.1%-15.8%2.038%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC147,233$2.06M0.7%-32.9%0.189%Search for SEC Filing on Google Icon
11/15/2024Point72 Asia Singapore Pte. Ltd.4,037$56K0.0%-88.6%0.005%Search for SEC Filing on Google Icon
11/14/2024Bellevue Group AG31,000$0.43M0.0%N/A0.040%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC264,273$3.70M0.3%+10.7%0.339%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC488,453$6.83M0.0%+70.1%0.626%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC163,175$2.28M0.0%-8.7%0.209%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 19,969$0.28M0.0%+20.9%0.026%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC19,000$0.27M0.2%N/A0.024%Search for SEC Filing on Google Icon
11/14/2024Healthcare of Ontario Pension Plan Trust Fund843,300$11.80M0.0%+37.1%1.080%Search for SEC Filing on Google Icon
11/13/2024Finepoint Capital LP1,782,267$24.93M1.8%+0.3%2.283%Search for SEC Filing on Google Icon
11/13/2024FMR LLC147,416$2.06M0.0%+27.5%0.189%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 47,045$0.66M0.0%+61.6%0.060%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.567,409$7.94M0.0%-0.2%0.727%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC20,226$0.28M0.0%N/A0.026%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.525,381$7.35M0.0%+11.2%0.673%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC3,871$54K0.0%-73.0%0.005%Search for SEC Filing on Google Icon
11/6/2024Oppenheimer & Co. Inc.48,139$0.67M0.0%N/A0.063%Search for SEC Filing on Google Icon
11/5/2024Aigen Investment Management LP12,180$0.17M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC27,951$0.39M0.0%-67.0%0.037%Search for SEC Filing on Google Icon
10/29/2024Emerald Advisers LLC1,960,659$27.43M1.1%+19.8%2.563%Search for SEC Filing on Google Icon
10/29/2024Emerald Mutual Fund Advisers Trust1,185,709$16.59M0.9%+26.0%1.550%Search for SEC Filing on Google Icon
10/28/2024Oak Ridge Investments LLC55,339$0.77M0.1%-3.9%0.072%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC94,736$1.33M0.1%+24.4%0.124%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.14,712$0.21M0.0%+64.5%0.019%Search for SEC Filing on Google Icon
10/24/2024Nisa Investment Advisors LLC4,846$68K0.0%-16.1%0.006%Search for SEC Filing on Google Icon
10/24/2024Semanteon Capital Management LP36,699$0.51M0.3%N/A0.048%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.1,374,522$19.23M0.0%-37.9%1.806%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.36,604$0.51M0.0%-9.5%0.048%Search for SEC Filing on Google Icon
10/11/2024Creative Planning23,938$0.34M0.0%+4.3%0.031%Search for SEC Filing on Google Icon
10/8/2024CWM LLC4,999$70K0.0%+158.5%0.007%Search for SEC Filing on Google Icon
10/7/2024Diversified Trust Co11,532$0.16M0.0%N/A0.015%Search for SEC Filing on Google Icon
9/20/2024Healthcare of Ontario Pension Plan Trust Fund615,000$5.06M0.0%+203.0%0.804%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC346,068$2.85M0.0%-0.6%0.452%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.35,377$0.29M0.1%N/A0.046%Search for SEC Filing on Google Icon
8/16/2024Forefront Analytics LLC13,317$0.11M0.1%+10.2%0.017%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC2,949,335$24.24M0.0%+33.9%3.856%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC74,069$0.61M0.0%+55.7%0.097%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.35,377$0.29M0.1%N/A0.046%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC15,580$0.13M0.0%-35.3%0.020%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC346,068$2.85M0.0%-0.6%0.452%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd21,315$0.18M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/14/2024Bank of Montreal Can75,919$0.63M0.0%N/A0.099%Search for SEC Filing on Google Icon
8/14/2024DRW Securities LLC11,598$95K0.0%N/A0.015%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC14,457$0.12M0.0%-21.5%0.019%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC33,836$0.28M0.0%-63.1%0.044%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.14,226$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd54,262$0.45M0.0%+110.5%0.071%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC48,994$0.40M0.0%-8.4%0.064%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.11,071$91K0.0%-60.6%0.014%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC2,203,814$18.12M0.0%-23.0%2.895%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.41,717$0.34M0.0%N/A0.055%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC76,174$0.63M0.0%+3.8%0.100%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC14,336$0.12M0.0%+240.6%0.019%Search for SEC Filing on Google Icon
8/6/2024Emerald Advisers LLC1,637,146$13.46M0.6%-6.4%2.150%Search for SEC Filing on Google Icon
8/6/2024Emerald Mutual Fund Advisers Trust941,265$7.74M0.4%-29.1%1.236%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC144,901$1.19M0.0%+202.6%0.190%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC84,817$0.70M0.0%-9.2%0.111%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System19,176$0.16M0.0%-7.1%0.025%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers125,660$1.03M0.0%+17.4%0.165%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.10,288$85K0.0%-44.7%0.014%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.90,881$0.75M0.0%N/A0.119%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp264,816$2.18M0.0%+18.3%0.348%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.2,214,099$18.20M0.0%+912.5%2.908%Search for SEC Filing on Google Icon
7/17/2024Oak Ridge Investments LLC57,584$0.47M0.0%-12.7%0.076%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC16,884$0.14M0.0%N/A0.022%Search for SEC Filing on Google Icon
7/11/2024Talbot Financial LLC63,546$0.52M0.1%N/A0.083%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System74,883$0.58M0.0%-5.0%0.098%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.1,124,685$8.67M0.0%-34.5%1.477%Search for SEC Filing on Google Icon
5/16/2024Bayesian Capital Management LP22,935$0.18M0.0%N/A0.030%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD31,009$0.24M0.0%+10.5%0.041%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC125,000$0.96M0.1%N/A0.164%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC4,101$32K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/14/2024Healthcare of Ontario Pension Plan Trust Fund203,000$1.57M0.0%-68.0%0.267%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC47,881$0.37M0.0%N/A0.063%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.6,265,829$48.31M0.0%+13.6%8.233%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System19,235$0.15M0.0%-7.5%0.025%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC18,421$0.14M0.0%+9.2%0.024%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.184,623$1.42M0.0%+79.2%0.243%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP58,601$0.45M0.0%N/A0.077%Search for SEC Filing on Google Icon
5/1/2024Oak Ridge Investments LLC65,926$0.51M0.1%+13.3%0.087%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.50,178$0.39M0.0%+8.1%0.066%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.14,652$0.11M0.0%+68.6%0.019%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.218,680$1.69M0.0%-13.9%0.287%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC73,400$0.57M0.0%+4.5%0.096%Search for SEC Filing on Google Icon
4/17/2024Hennion & Walsh Asset Management Inc.40,790$0.31M0.0%+14.4%0.054%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC93,417$0.72M0.0%N/A0.123%Search for SEC Filing on Google Icon
3/21/2024Healthcare of Ontario Pension Plan Trust Fund635,277$5.71M0.0%N/A0.835%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC19,498$0.18M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/20/2024Quarry LP4,500$40K0.0%-55.0%0.006%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC1,018,812$9.16M1.3%+76.4%1.356%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Travere Therapeutics logo
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Read More on Travere Therapeutics

Today's Range

Now: $19.58
Low: $19.37
High: $19.99

50 Day Range

MA: $17.28
Low: $13.65
High: $19.85

52 Week Range

Now: $19.58
Low: $5.12
High: $20.33

Volume

375,228 shs

Average Volume

1,390,949 shs

Market Capitalization

$1.53 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Travere Therapeutics?

Travere Therapeutics' top insider investors include:
  1. Eric M Dube (CEO)
  2. Peter Heerma (Insider)
  3. William E Rote (SVP)
  4. Jeffrey A Meckler (Director)
  5. Christopher R Cline (CFO)
  6. Jula Inrig (Insider)
  7. Elizabeth E Reed (SVP)
  8. Sandra Calvin (CAO)
  9. Gary A Lyons (Director)
Learn More about top insider investors at Travere Therapeutics.

Who are the major institutional investors of Travere Therapeutics?

Travere Therapeutics' top institutional shareholders include:
  1. State Street Corp — 3.51%
  2. Emerald Advisers LLC — 2.56%
  3. Finepoint Capital LP — 2.28%
  4. Geode Capital Management LLC — 2.22%
  5. Jacobs Levy Equity Management Inc. — 2.04%
  6. Assenagon Asset Management S.A. — 1.81%
Learn More about top institutional investors of Travere Therapeutics stock.

Which institutional investors are selling Travere Therapeutics stock?

In the previous quarter, TVTX stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. State Street Corp
  3. Jacobs Levy Equity Management Inc.
  4. HighVista Strategies LLC
  5. Y Intercept Hong Kong Ltd
  6. Los Angeles Capital Management LLC
  7. XTX Topco Ltd
  8. Point72 Asia Singapore Pte. Ltd.
In the previous year, company insiders that have sold Travere Therapeutics company stock include:
  1. Eric M Dube (CEO)
  2. Peter Heerma (Insider)
  3. William E Rote (SVP)
  4. Jeffrey A Meckler (Director)
  5. Christopher R Cline (CFO)
  6. Jula Inrig (Insider)
  7. Elizabeth E Reed (SVP)
  8. Sandra Calvin (CAO)
  9. Gary A Lyons (Director)
Learn More investors selling Travere Therapeutics stock.

Which institutional investors are buying Travere Therapeutics stock?

In the last quarter, TVTX stock was bought by institutional investors including:
  1. Jane Street Group LLC
  2. Emerald Advisers LLC
  3. Emerald Mutual Fund Advisers Trust
  4. Healthcare of Ontario Pension Plan Trust Fund
  5. Walleye Capital LLC
  6. Two Sigma Advisers LP
  7. Parkman Healthcare Partners LLC
  8. Geode Capital Management LLC